Elderly Completed Phase 2 Trials for Lemborexant (DB11951)

IndicationStatusPhase
DBCOND0031327 (Elderly)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01995838A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic InsomniaTreatment